
Health
Japan’s Kowa says ivermectin effective against Omicron in phase III trial
February 1, 2022
|
TOKYO (Reuters) – Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite human drug ivermectin has been found effective for treating the Omicron variant of
Read More